DSP 8658

Drug Profile

DSP 8658

Alternative Names: DSP-8658

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Dainippon Sumitomo Pharma
  • Class Antihyperglycaemics
  • Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor gamma agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Alzheimer's disease; Type 2 diabetes mellitus

Most Recent Events

  • 30 Sep 2013 Discontinued - Phase-I for Alzheimer's disease & Type-2 diabetes mellitus in USA (PO)
  • 16 Sep 2011 Sunovion completes a phase I trial in Type-2 diabetes mellitus in USA (NCT01042106)
  • 03 Feb 2011 Phase-I clinical trials in Alzheimer's disease in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top